Literature DB >> 1355441

The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat.

A F Sullivan1, E A Kalso, H J McQuay, A H Dickenson.   

Abstract

The actions of the selective alpha 2-adrenoceptor agonist dexmedetomidine were examined on the nociceptive C and innocuous A beta fibre-evoked responses of dorsal horn neurones to transcutaneous electrical stimulation in the intact anaesthetized rat. C fibre-evoked responses were dose dependently reduced by intrathecal dexmedetomidine--to a maximum 86 +/- 6% inhibition by 10 micrograms of the agonist. The ED50 for inhibition of C fibre responses was estimated to be 2.5 micrograms. A beta-evoked responses were inhibited to a lesser degree--a maximum 54 +/- 8% inhibition after 10 micrograms dexmedetomidine. The antinociceptive effects of dexmedetomidine were reversed by the alpha 2-adrenoceptor antagonist atipamezole and the opioid antagonist naloxone. The results are discussed with reference to adrenergic and opioid mechanisms in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355441     DOI: 10.1016/0014-2999(92)90617-d

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Psychosedation with dexmedetomidine hydrochloride during minor oral surgery.

Authors:  Kiichi Taniyama; Hideki Oda; Kazuko Okawa; Katsuhito Himeno; Koki Shikanai; Tohru Shibutani
Journal:  Anesth Prog       Date:  2009

3.  Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: an in vivo patch-clamp analysis of analgesic mechanisms.

Authors:  Yusuke Funai; Anthony Edward Pickering; Daisuke Uta; Kiyonobu Nishikawa; Takashi Mori; Akira Asada; Keiji Imoto; Hidemasa Furue
Journal:  Pain       Date:  2013-12-16       Impact factor: 6.961

Review 4.  Spinal opioid systems in inflammation.

Authors:  L Stanfa; A Dickenson
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

5.  Effects of spinal naloxone and naltrindole on the antinociceptive action of intrathecally administered dexmedetomidine.

Authors:  Y Takano; M Takano; I Sato; T L Yaksh
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

6.  Reflex wind-up in early chronic spinal injury: plasticity of motor outputs.

Authors:  Michael D Johnson; Alain Frigon; Marie-France Hurteau; Charlette Cain; C J Heckman
Journal:  J Neurophysiol       Date:  2017-03-01       Impact factor: 2.714

7.  Dexmedetomidine Supported Office Based Genioplasty: A Pilot Study.

Authors:  Prashant Kumar; Kannu Priya; Shruti Kirti; Sanjay Johar; Virendra Singh
Journal:  J Maxillofac Oral Surg       Date:  2015-01-06

8.  The synergistic antinociceptive interactions of morphine and dexmedetomidine in rats with nerve-ligation injury.

Authors:  Aa Kabalak; E Ekmekçioğlu; A Ceylan; K Kahveci
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

Review 9.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

10.  [Antinociceptive effects of alpha(2)-adrenoceptor agonists ("analgesic" actions in animal experiments)agonists ("analgesic" actions in animal experiments).].

Authors:  I Jurna
Journal:  Schmerz       Date:  1995-11       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.